Open AccessNew‐onset pemphigus foliaceus following SARS‐CoV‐2 infection and unmasking multiple sclerosis: A case report
Author(s) -
Mohaghegh Fatemeh,
Hatami Parvaneh,
Refaghat Arezoo,
Mehdizadeh Mohammadjavad,
Aryanian Zeinab,
Mohandesi Nessa Aghazadeh,
Afshar Zeinab Mohseni
Publication year - 2022
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.5910
Subject(s) - pemphigus foliaceus , medicine , covid-19 , virology , dermatology , pemphigus , multiple sclerosis , immunology , pathology , infectious disease (medical specialty) , disease , autoantibody , antibody , outbreak
Abstract Development of pemphigus foliaceus (PF) following SARS‐CoV‐2 infection has only been reported in one patient who had received Bamlanivimab and thus might be considered as a drug‐induced case of PF. Here, we reported the first case of PF arising solely after COVID infection without taking any culprit drug.